This summary was created by AI, based on 2 opinions in the last 12 months.
Based on the reviews from different experts, it is evident that Marsh & McLennan is a strong and diversified company with a focus on reinsurance and consulting businesses. The recent acquisition further signifies their growth potential and ability to deliver double-digit returns over the cycle. The company has consistently earned positive reviews and is considered a good investment option for both short-term and long-term gains.
It consistently earns, a good company. Buy some now and buy some more cheaper.
Marsh & McLennan is a American stock, trading under the symbol MMC-N on the New York Stock Exchange (MMC). It is usually referred to as NYSE:MMC or MMC-N
In the last year, 1 stock analyst published opinions about MMC-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Marsh & McLennan.
Marsh & McLennan was recommended as a Top Pick by on . Read the latest stock experts ratings for Marsh & McLennan.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Marsh & McLennan In the last year. It is a trending stock that is worth watching.
On 2024-04-24, Marsh & McLennan (MMC-N) stock closed at a price of $199.91.
Their reinsurance business increases when premiums increase. Also operate consulting businesses. Recently bought it. Expects double-digit returns over the cycle.
(Analysts’ price target is $201.35)